Anakinra: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 June 2024

  • curprev 00:1300:13, 12 June 2024‎ Ai talk contribs‎ 4,691 bytes +4,691‎ Created page with "== Introduction == Anakinra is a recombinant, non-glycosylated version of the human interleukin-1 receptor antagonist (IL-1Ra) used primarily in the treatment of rheumatoid arthritis and other inflammatory conditions. It is a biologic agent that targets the inflammatory cytokine interleukin-1 (IL-1), which plays a crucial role in the pathogenesis of various autoimmune and inflammatory diseases. Anakinra is produced using recombinant DNA technology in Escherichia coli...."
Retrieved from "https://canonica.ai/page/Anakinra"